Dr. Eric Marshall Knoche, MD

Dr. Knoche practices at Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health.

Dr. Knoche's NPI, 1184834624, was assigned on May 23, 2007. Dr. Knoche graduated from Washington University School of Medicine in 2006. Dr. Knoche holds Missouri license 2009012797.

Dr. Knoche's primary practice is Barnes-Jewish Hospital, at One Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110 in St. Louis City. The practice phone is (314) 747-3000. Dr. Knoche also practices at Barnes-Jewish Hospital, 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110.

Dr. Knoche's primary practice is Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health. Dr. Knoche is also affiliated with Missouri Baptist Medical Center. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Knoche to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Knoche practices, 5 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Knoche's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Knoche is licensed in Missouri.

CMS data shows 8,830 Medicare services from Dr. Knoche across 21 procedure codes in 2024, for 165 Medicare patients. Medicare paid $40,565 for them. Every service was in an office.

CMS counts 165 Medicare patients who saw Dr. Knoche in 2024. The largest group is 65 to 74, with 83 patients. 72% of them have cancer, and 65% have high cholesterol. Their average risk score is 2.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Knoche's median patient age at 73, with 17% women.

In 2024, Dr. Knoche wrote 765 Medicare Part D claims for 91 patients. 78% of them were for generic drugs. CMS names the drug for 548 of them, across 20 drugs with 11 or more claims each, at $2,471,100 in total drug cost. In 2023, CMS named 425 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Knoche for performance year 2024, reported as part of a group. Dr. Knoche accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 13 papers to Dr. Knoche, published from 2015 to 2025. 2022 was the busiest year, with 3. The most frequent topics are Nitriles, Androgen Antagonists and Antineoplastic Combined Chemotherapy Protocols. Dr. Knoche has published most often in Prostate Cancer Prostatic Dis. Dr. Knoche's most frequent co-authors are Melissa Andrea Reimers, MD, John Paul Christodouleas, MD and Benjamin Walker Fischer-Valuck, MD.

Dmand AI links Dr. Knoche to 10 clinical trials, 4 of them phase 3 studies. 8 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Carcinoma, Bronchogenic and Rectal Diseases. Washington University School of Medicine sponsors the most, 4.

CMS Open Payments shows 30 general payments to Dr. Knoche from 12 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 85% of the total. Abbvie Inc. paid the most, $237.

Dr. Knoche graduated from Washington University School of Medicine in 2006.